1. |
Murphy EM, Farquharson SM, Moran BJ. Management of an unexpected appendiceal neoplasm. Br J Surg, 2006, 93(7): 783-792.
|
2. |
Garland-Kledzik M, Maithel S, Jafari MD, et al. Misdiagnosis of appendiceal neoplasms as ovarian tumors: impact of prior gynecologic surgery on definitive cytoreduction and HIPEC. Eur J Surg Oncol, 2022, 48(2): 449-454.
|
3. |
Behera PK, Rath PK, Panda R, et al. Primary appendiceal mucinous adenocarcinoma. Indian J Surg, 2011, 73(2): 146-148.
|
4. |
Gortchev G, Tomov S, Dimitrov D, et al. Appendiceal mucocele presenting as a right adnexal mass: a case report. Obstet Gynecol Int, 2010, 2010: 281053. doi: 10.1155/2010/281053.
|
5. |
程研, 谭震, 王长顺. 原发性阑尾腺癌的临床特点及预后影响因素. 中华临床医师杂志 (电子版), 2013, 7(8): 3568-3570.
|
6. |
Misdraji J. Appendiceal mucinous neoplasms: controversial issues. Arch Pathol Lab Med, 2010, 134(6): 864-870.
|
7. |
Glasgow SC, Gaertner W, Stewart D, et al. The American Society of Colon and Rectal Surgeons, Clinical Practice Guidelines for the Management of Appendiceal Neoplasms. Dis Colon Rectum, 2019, 62(12): 1425-1438.
|
8. |
吕靖芳, 汤庆超. 中国阑尾肿瘤多学科综合治疗专家共识 (2021版). 中华结直肠疾病电子杂志, 2021, 10(3): 225-231.
|
9. |
Nitecki SS, Wolff BG, Schlinkert R, et al. The natural history of surgically treated primary adenocarcinoma of the appendix. Ann Surg, 1994, 219(1): 51-57.
|
10. |
Shaib WL, Assi R, Shamseddine A, et al. Appendiceal mucinous neoplasms: diagnosis and management. Oncologist, 2017, 22(9): 1107-1116.
|
11. |
武颖超, 文龙, 窦伟冬, 等. 原发性阑尾肿瘤的临床病理分析及手术决策. 中华胃肠外科杂志, 2021, 24(12): 1065-1072.
|
12. |
Cortina R, McCormick J, Kolm P, et al. Management and prognosis of adenocarcinoma of the appendix. Dis Colon Rectum, 1995, 38(8): 848-852.
|
13. |
Tsang ES, McConnell YJ, Schaeffer DF, et al. Outcomes of surgical and chemotherapeutic treatments of goblet cell carcinoid tumors of the appendix. Ann Surg Oncol, 2018, 25(8): 2391-2399.
|
14. |
Pai RK, Beck AH, Norton JA, et al. Appendiceal mucinous neoplasms: clinicopathologic study of 116 cases with analysis of factors predicting recurrence. Am J Surg Pathol, 2009, 33(10): 1425-1439.
|
15. |
Connor SJ, Hanna GB, Frizelle FA. Appendiceal tumors: retrospective clinicopathologic analysis of appendiceal tumors from 7,970 appendectomies. Dis Colon Rectum, 1998, 41(1): 75-80.
|
16. |
Esmer-Sanchez DD, Martinez-Ordaz JL, Roman-Zepeda P, et al. Appendiceal tumors. Clinicopathologic review of 5,307 appendectomies. Cir Cir, 2004, 72(5): 375-378.
|
17. |
Tang LH, Shia J, Soslow RA, et al. Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendix. Am J Surg Pathol, 2008, 32(10): 1429-1443.
|
18. |
Bucher P, Gervaz P, Ris F, et al. Surgical treatment of appendiceal adenocarcinoid (goblet cell carcinoid). World J Surg, 2005, 29(11): 1436-1439.
|
19. |
Varisco B, McAlvin B, Dias J, et al. Adenocarcinoid of the appendix: is right hemicolectomy necessary? A meta-analysis of retrospective chart reviews. Am Surg, 2004, 70(7): 593-599.
|
20. |
Pŭrvanov P. Primary malignant appendiceal tumors. Khirurgiia (Sofiia), 1997, 50(4): 46-49.
|
21. |
Shenoy S. Goblet cell carcinoids of the appendix: tumor biology, mutations and management strategies. World J Gastrointest Surg, 2016, 8(10): 660-669.
|
22. |
Shaib W, Krishna K, Kim S, et al. Appendiceal neuroendocrine, goblet and signet-ring cell tumors: a spectrum of diseases with different patterns of presentation and outcome. Cancer Res Treat, 2016, 48(2): 596-604.
|
23. |
Wang G, Li Q, Chen W. Chemotherapy in the treatment of different histological types of appendiceal cancers: a SEER based study. BMC Cancer, 2021, 21(1): 778. doi: 10.1186/s12885-021-08502-3.
|
24. |
Almasri SS, Paniccia A, Hammad AY, et al. The role of adjuvant chemotherapy following right hemicolectomy for non-metastatic mucinous and nonmucinous appendiceal adenocarcinoma. J Gastrointest Surg, 2022, 26(1): 171-180.
|
25. |
Lieu CH, Lambert LA, Wolff RA, et al. Systemic chemotherapy and surgical cytoreduction for poorly differentiated and signet ring cell adenocarcinomas of the appendix. Ann Oncol, 2012, 23(3): 652-658.
|
26. |
Zakka K, Williamson S, Jiang R, et al. Is adjuvant chemotherapy beneficial for stage Ⅱ–Ⅲ goblet cell carcinoid/goblet cell adenocarcinoma of the appendix? Surg Oncol, 2021, 36: 120-129.
|
27. |
Asare EA, Compton CC, Hanna NN, et al. The impact of stage, grade, and mucinous histology on the efficacy of systemic chemotherapy in adenocarcinomas of the appendix: analysis of the National Cancer Data Base. Cancer, 2016, 122(2): 213-221.
|
28. |
Alexander-Sefre F, Chandrakumaran K, Banerjee S, et al. Elevated tumour markers prior to complete tumour removal in patients with pseudomyxoma peritonei predict early recurrence. Colorectal Dis, 2005, 7(4): 382-386.
|
29. |
Carmignani CP, Hampton R, Sugarbaker CE, et al. Utility of CEA and CA19-9 tumor markers in diagnosis and prognostic assessment of mucinous epithelial cancers of the appendix. J Surg Oncol, 2004, 87(4): 162-166.
|
30. |
Fournier K, Rafeeq S, Taggart M, et al. Low-grade appendiceal mucinous neoplasm of uncertain malignant potential (LAMN-UMP): prognostic factors and implications for treatment and follow-up. Ann Surg Oncol, 2017, 24(1): 187-193.
|
31. |
Taflampas P, Dayal S, Chandrakumaran K, et al. Pre-operative tumour marker status predicts recurrence and survival after complete cytoreduction and hyperthermic intraperitoneal chemotherapy for appendiceal Pseudomyxoma Peritonei: analysis of 519 patients. Eur J Surg Oncol, 2014, 40(5): 515-520.
|
32. |
Baratti D, Kusamura S, Martinetti A, et al. Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol, 2007, 14(8): 2300-2308.
|
33. |
van Ruth S, Hart AA, Bonfrer JM, et al. Prognostic value of baseline and serial carcinoembryonic antigen and carbohydrate antigen 199 measurements in patients with pseudomyxoma peritonei treated with cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol, 2002, 9(10): 961-967.
|
34. |
Chua TC, Chong CH, Liauw W, et al. Inflammatory markers in blood and serum tumor markers predict survival in patients with epithelial appendiceal neoplasms undergoing surgical cytoreduction and intraperitoneal chemotherapy. Ann Surg, 2012, 256(2): 342-349.
|
35. |
张体硕. 预后营养指数 (PNI) 及炎症标记物对卵巢癌预后的影响. 吉林: 吉林大学, 2021.
|
36. |
Sugarbaker PH. Epithelial appendiceal neoplasms. Cancer J, 2009, 15(3): 225-235.
|